Furthermore, identifying HCA1-activation as the mechanism through which L-lactate increases angiogenesis and reduces the lesion after stroke opens the development and testing of more specific and potent HCA1 agonists that may be used as stroke therapeutics in the future. Here, HCAR1 is linked to stroke disorder.